PERSPECTA

News from every angle

← Back to headlines

Propanc Biopharma, Inc. Reports GAAP EPS of -$0.30

Propanc Biopharma, Inc. has released its GAAP earnings per share, reporting a loss of $0.30.

18 Feb, 20:42 — 18 Feb, 20:42

PostShare